123STA T . 3 5 53 CON C UR R E NT RESO L UT I ONS —J UNE 8, 2 0 0 9Lead e ro r his desi gn ee , i t stand ad j o u rned unti l2p.m .on T uesda y , J une2,2 0 0 9 , or until the time o f any reassem b ly pursuant to se c tion 2 of this concurrent resolution, w hiche v er occurs first
and that when the S enate recesses or adjourns on any day from Thurs - day, M ay2 1 , 2009, through Sunday, May 2 4 , 2009, on a motion offered pursuant to this concurrent resolution by its Majority Leader or his designee, it stand recessed or adjourned until noon on Mon- day, June 1, 2009, or such other time on that day as may be specified in the motion to recess or adjourn, or until the time of any reassembly pursuant to section 2 of this concurrent resolu- tion, whichever occurs first.S EC . 2. The Spea k er of the H ouse and the Majority Leader of the Senate, or their respective designees, acting jointly after consultation with the Minority Leader of the House and the Minority Leader of the Senate, shall notify the Members of the House and the Senate, respectively, to reassemble at such place and time as they may designate if, in their opinion, the public interest shall warrant it. A greed to May 21, 2009. SU S ANG.KOME NG L O B AL R A C E F OR TH E CURE — RECOGN I TION AN D SU P PORT W hereas breast cancer is the most fre q uently diagnosed cancer in women worldwide, with more than 1, 3 00,000 diagnosed each year; Whereas breast cancer is the leading cause of death among women worldwide, more than 4 65 ,000 die from the disease each year, and a woman dies from breast cancer every 6 8 seconds; Whereas there are more than 2,500,000 breast cancer survivors alive in the U nited States today, the largest group of all cancer survivors; Whereas a woman has a one-in-eight lifetime risk of developing breast cancer, and only a small percentage of cases are due to heredity; Whereas incidence rates for breast cancer are increasing by as much as five percent annually in low-resource countries; Whereas, since its inception, Susan G . K omen for the C ure has invested more than $ 1,300,000,000 in breast cancer research, education, and community health services that have raised aware- ness and improved treatment, helping more people survive the disease and creating a strong support community of breast cancer survivors; Whereas publicly and privately funded research has resulted in treatment that has raised the 5-year survival rate for women with locali z ed breast cancer from 80 percent in the 1950s to 98 percent in 2008; Whereas the Susan G. Komen R ace for the Cure Series is the organization ’ s signature program and is the world’s largest and most successful education and fundraising event for breast cancer; June8,20 0 9[H.Co n. R e s . 1 09 ]
